Cargando…
Long-Term Release of Dexamethasone With a Polycaprolactone-Coated Electrode Alleviates Fibrosis in Cochlear Implantation
Cochlear implantation (CI) is the major treatment for severe sensorineural hearing loss. However, the fibrotic tissue forming around the electrodes reduces the treatment effectiveness of CI. Dexamethasone (DEX) is usually applied routinely in perioperative treatment of cochlear implantation (CI), bu...
Autores principales: | Chen, Dongxiu, Luo, Yanjing, Pan, Jing, Chen, Anning, Ma, Dong, Xu, Muqing, Tang, Jie, Zhang, Hongzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589109/ https://www.ncbi.nlm.nih.gov/pubmed/34778254 http://dx.doi.org/10.3389/fcell.2021.740576 |
Ejemplares similares
-
Preparation, characterization, and in vitro/vivo evaluation of dexamethasone/poly(ε-caprolactone)-based electrode coatings for cochlear implants
por: Luo, Yanjing, et al.
Publicado: (2021) -
Electrical stimulation of cochlear implant promotes activation of macrophages and fibroblasts under inflammation
por: Zhang, Dingling, et al.
Publicado: (2023) -
Gpr125 Marks Distinct Cochlear Cell Types and Is Dispensable for Cochlear Development and Hearing
por: Sun, Haiying, et al.
Publicado: (2021) -
A Neurophysiological Study of Musical Pitch Identification in Mandarin-Speaking Cochlear Implant Users
por: Cai, Jieqing, et al.
Publicado: (2020) -
Cochlear Development; New Tools and Approaches
por: Kelley, Matthew W.
Publicado: (2022)